Table 4. Intragroup and Intergroup Comparisons of Peak Portal Vein Blood Flow and Mean Maximum Portal Vein Blood Flow Velocity of the two Groups Before and After Treatment.
| Group | 0 Week | 12th Week | 24th Week | 36th Week | 48th Week | Number |
|---|---|---|---|---|---|---|
| Treatment group | 33 | |||||
| DPV, mm | 12.06 ± 1.00 | 11.64 ± 1.11 | 11.73 ± 1.31 | 11.42 ± 1.30a,b | 11.21 ± 1.05a,b | |
| PVmax, cm/s | 18.61 ± 3.22 | 19.17 ± 3.08 | 19.29 ± 2.79 | 20.43 ± 2.42a,b | 20.03 ± 2.51a,b | |
| PVmean, cm/s | 15.78 ± 3.41 | 16.54 ± 2.84 | 16.70 ± 2.44 | 17.54 ± 3.16a,b | 17.84 ± 3.40a,b | |
| Control group | 35 | |||||
| DPV, mm | 12.03 ± 0.92 | 11.77 ± 1.21 | 11.86 ± 1.17 | 12.26 ± 1.40 | 12.14 ± 1.29 | |
| PVmax, cm/s | 19.41 ± 3.79 | 19.47 ± 2.37 | 18.99 ± 3.20 | 18.89 ± 3.45 | 18.49 ± 2.84 | |
| PVmean, cm/s | 16.02 ± 4.42 | 16.49 ± 2.84 | 15.81 ± 2.68 | 15.72 ± 2.67 | 15.65 ± 3.55 |
aP < 0.05, compared to before treatment.
bP < 0.05, compared to the control group.